TY - JOUR
T1 - UNC93B1 variants underlie TLR7-dependent autoimmunity
AU - Wolf, Christine
AU - Lim, Ee Lyn
AU - Mokhtari, Mohammad
AU - Kind, Barbara
AU - Odainic, Alexandru
AU - Lara-Villacanas, Eusebia
AU - Koss, Sarah
AU - Mages, Simon
AU - Menzel, Katharina
AU - Engel, Kerstin
AU - Dückers, Gregor
AU - Bernbeck, Benedikt
AU - Schneider, Dominik T.
AU - Siepermann, Kathrin
AU - Niehues, Tim
AU - Goetzke, Carl Christoph
AU - Durek, Pawel
AU - Minden, Kirsten
AU - Dörner, Thomas
AU - Stittrich, Anna
AU - Szelinski, Franziska
AU - Guerra, Gabriela Maria
AU - Massoud, Mona
AU - Bieringer, Markus
AU - de Oliveira Mann, Carina C.
AU - Beltrán, Eduardo
AU - Kallinich, Tilmann
AU - Mashreghi, Mir Farzin
AU - Schmidt, Susanne V.
AU - Latz, Eicke
AU - Klughammer, Johanna
AU - Majer, Olivia
AU - Lee-Kirsch, Min Ae
N1 - Publisher Copyright:
© 2024 American Association for the Advancement of Science. All rights reserved.
PY - 2024/2
Y1 - 2024/2
N2 - UNC93B1 is critical for trafficking and function of nucleic acid–sensing Toll-like receptors (TLRs) TLR3, TLR7, TLR8, and TLR9, which are essential for antiviral immunity. Overactive TLR7 signaling induced by recognition of self–nucleic acids has been implicated in systemic lupus erythematosus (SLE). Here, we report UNC93B1 variants (E92G and R336L) in four patients with early-onset SLE. Patient cells or mouse macrophages carrying the UNC93B1 variants produced high amounts of TNF-α and IL-6 and upon stimulation with TLR7/TLR8 agonist, but not with TLR3 or TLR9 agonists. E92G causes UNC93B1 protein instability and reduced interaction with TLR7, leading to selective TLR7 hyperactivation with constitutive type I IFN signaling. Thus, UNC93B1 regulates TLR subtype–specific mechanisms of ligand recognition. Our findings establish a pivotal role for UNC93B1 in TLR7-dependent autoimmunity and highlight the therapeutic potential of targeting TLR7 in SLE.
AB - UNC93B1 is critical for trafficking and function of nucleic acid–sensing Toll-like receptors (TLRs) TLR3, TLR7, TLR8, and TLR9, which are essential for antiviral immunity. Overactive TLR7 signaling induced by recognition of self–nucleic acids has been implicated in systemic lupus erythematosus (SLE). Here, we report UNC93B1 variants (E92G and R336L) in four patients with early-onset SLE. Patient cells or mouse macrophages carrying the UNC93B1 variants produced high amounts of TNF-α and IL-6 and upon stimulation with TLR7/TLR8 agonist, but not with TLR3 or TLR9 agonists. E92G causes UNC93B1 protein instability and reduced interaction with TLR7, leading to selective TLR7 hyperactivation with constitutive type I IFN signaling. Thus, UNC93B1 regulates TLR subtype–specific mechanisms of ligand recognition. Our findings establish a pivotal role for UNC93B1 in TLR7-dependent autoimmunity and highlight the therapeutic potential of targeting TLR7 in SLE.
UR - http://www.scopus.com/inward/record.url?scp=85185843289&partnerID=8YFLogxK
U2 - 10.1126/sciimmunol.adi9769
DO - 10.1126/sciimmunol.adi9769
M3 - Article
C2 - 38207055
AN - SCOPUS:85185843289
SN - 2470-9468
VL - 9
JO - Science Immunology
JF - Science Immunology
IS - 92
M1 - eadi9769
ER -